LifeArc (MRC-Translation gap funding)
Published by OXFORD INVENTION FUND (OIF)
Industrial Development or SMEClinical ReasearchPrivateBasic ResearchPreclinical Research
Sources of funding for the Innovation in Rare Diseases
Published by OXFORD INVENTION FUND (OIF)
Industrial Development or SMEClinical ReasearchPrivateBasic ResearchPreclinical ResearchPublished by REGIONE SICILIA
PublicBasic ResearchClinical ResearchPreclinical ResearchThe OP ERDF Sicily 2014/2020 was built on the basis of an analysis of the relevant needs, problems and opportunities that characterize the Sicilian Region with the involvement of the territory through a path of public consultation. The thematic objectives and investment priorities have been identified on the basis of EU Regulations n. 1301/2013 and n. 1303/2013 and the Partnership Agreement for Italy 2014/2020.
View this resource Bookmark this resourcePublished by Boehringer Ingelheim
Industrial Development or SMEVenture Capital or Angel InvestmentPrivateBasic ResearchClinical ResearchPreclinical ResearchPublished by ITALIAN ANGELS FOR BIOTECH
Basic ResearchClinical ResearchPreclinical ResearchIndustrial Development or SMEVenture Capital or Angel InvestmentPrivatePublished by ITALIAN ANGELS FOR GROWTH
Clinical ResearchPreclinical ResearchIndustrial Development or SMEVenture Capital or Angel InvestmentPrivateBasic ResearchGenextra is one of Italy’s largest and most experienced life sciences investment firms.
View this resource Bookmark this resourcePanakes invest in ambitious early stage start-ups and SMEs with innovative products globally, mainly across Europe and Israel
View this resource Bookmark this resource